Synergistic induction of CX3CL1 by TNF alpha and IFN gamma in osteoblasts from rheumatoid arthritis: involvement of NF-kappa B and STAT-1 signaling pathways

References

• AggarwalBB2000Tumour necrosis factors receptor associated signalling molecules and their role in activation of apoptosis, JNK and NF-kappaBAnn Rheum Dis59Suppl 1i61611053079
   PubMedGoogle Scholar
• AhnSYChoCHParkKG2004Tumor necrosis factor-alpha induces fractalkine expression preferentially in arterial endothelial cells and mithramycin A suppresses TNF-alpha-induced fractalkine expressionAm J Pathol16416637215111313
   PubMed Web of Science ®Google Scholar
• AncutaPRaoRMosesA2003Fractalkine preferentially mediates arrest and migration of CD16+ monocytesJ Exp Med1971701712810688
   PubMed Web of Science ®Google Scholar
• BazanJFBaconKBHardimanG1997A new class of membrane-bound chemokine with a CX3C motifNature38564049024663
   PubMed Web of Science ®Google Scholar
• BlaschkeSKoziolekMSchwarzA2003Proinflammatory role of fractalkine (CX3CL1) in rheumatoid arthritisJ Rheumatol3019182712966591
   PubMed Web of Science ®Google Scholar
• BonizziGKarinM2004The two NF-kappaB activation pathways and their role in innate and adaptive immunityTrends Immunol25280815145317
   PubMed Web of Science ®Google Scholar
• ChandrasekarBMummidiSPerlaRP2003Fractalkine (CX3CL1) stimulated by nuclear factor kappaB (NF-kappaB)-dependent inflammatory signals induces aortic smooth muscle cell proliferation through an autocrine pathwayBiochem J3735475812729461
   PubMed Web of Science ®Google Scholar
• ChenSBaconKBLiL1998In vivo inhibition of CC and CX3C chemokine-induced leukocyte infiltration and attenuation of glomerulonephritis in Wistar-Kyoto (WKY) rats by vMIP-IIJ Exp Med18819389653095
   PubMed Web of Science ®Google Scholar
• ChenYMTuCJHungKY2003Inhibition by pentoxifylline of TNF-alpha-stimulated fractalkine production in vascular smooth muscle cells: evidence for mediation by NF-kappa B down-regulationBr J Pharmacol138950812642397
   PubMed Web of Science ®Google Scholar
• ChoyEHSPanayiGS2001Cytokine pathways and joint inflammation in rheumatoid arthritisN Engl J Med3449071611259725
   PubMed Web of Science ®Google Scholar
• GarciaGEXiaYChenS2000NF-kappaB-dependent fractalkine induction in rat aortic endothelial cells stimulated by IL-1beta, TNFalpha, and LPSJ Leukocyte Biol675778410770292
   PubMed Web of Science ®Google Scholar
• GartonKJGoughPJBlobelCP2001Tumor necrosis factor-a-converting enzyme (ADAM17) mediates the cleavage and shedding of fractalkine (CX3CL1)J Biol Chem27637993800111495925
   PubMed Web of Science ®Google Scholar
• HasegawaMSatoSEchigoT2005Up regulated expression of fractalkine/CX3CL1 and CX3CR1 in patients with systemic sclerosisAnn Rheum Dis6421815608300
   PubMed Web of Science ®Google Scholar
• HundhausenCMisztelaDBerkhoutTA2003The disintegrin-like metalloproteinase ADAM10 is involved in constitutive cleavage of CX3CL1 (fractalkine) and regulates CX3CL1-mediated cell-cell adhesionBlood10211869512714508
   PubMed Web of Science ®Google Scholar
• ImaiTHieshimaKHaskellC1997Identification and molecular characterization of fractalkine receptor CX3CR1, which mediates both leukocyte migration and adhesionCell91521309390561
   PubMed Web of Science ®Google Scholar
• JimiEGhoshS2005Role of nuclear factor-kappaB in the immune system and boneImmunol Rev20880716313342
   PubMed Web of Science ®Google Scholar
• KasamaTIsozakiTOdaiT2007Expression of angiopoietin-1 in osteoblasts and its inhibition by tumor necrosis factor-alpha and interferon-gammaTransl Res1492657317466926
   PubMed Web of Science ®Google Scholar
• KasamaTShiozawaFKobayashiK2001Vascular endothelial growth factor expression by activated synovial leukocytes in rheumatoid arthritis. Critical involvement of the interaction with synovial fibroblastsArthritis Rheum4425122411710707
   PubMed Web of Science ®Google Scholar
• KasperkovitzPVVerbeetNLSmeetsTJ2004Activation of the STAT1 pathway in rheumatoid arthritisAnn Rheum Dis63233914962955
   PubMed Web of Science ®Google Scholar
• KimSKogaTIsobeM2003Stat1 functions as a cytoplasmic attenuator of Runx2 in the transcriptional program of osteoblast differentiationGenes Dev1719799112923053
   PubMed Web of Science ®Google Scholar
• KlimiukPAGoronzyJJBjor nssonJ1997Tissue cytokine patterns distinguish variants of rheumatoid synovitisAm J Pathol151131199358757
   PubMed Web of Science ®Google Scholar
• KunkelSLLukacsNWKasamaT1996The role of chemokines in inflammatory joint diseaseJ Leukocyte Biol586128558068
   PubMed Web of Science ®Google Scholar
• KurokouchiKKambeFYasukawaK1998TNF-alpha increases expression of IL-6 and ICAM-1 genes through activation of NF-kappaB in osteoblast-like ROS17/2.8 cellsJ Bone Miner Res13129099718198
   PubMed Web of Science ®Google Scholar
• LiQVermaIM2002NF-kappaB regulation in the immune systemNat Rev Immunol27253412360211
   PubMed Web of Science ®Google Scholar
• LisignoliGToneguzziSGrassiF2002Different chemokines are expressed in human arthritic bone biopsies: IFN-gamma and IL-6 differently modulate IL-8, MCP-1 and rantes production by arthritic osteoblastsCytokine20231812550108
   PubMed Web of Science ®Google Scholar
• LisignoliGToneguzziSPozziC1999Proinflammatory cytokines and chemokine production and expression by human osteoblasts isolated from patients with rheumatoid arthritis and osteoarthritisJ Rheumatol26791910229398
   PubMed Web of Science ®Google Scholar
• LuJKasamaTKobayashiK2000Vascular endothelial growth factor expression and regulation of murine collagen-induced arthritisJ Immunol1645922710820274
   PubMed Web of Science ®Google Scholar
• LudwigABerkhoutTMooresK2002Fractalkine is expressed by smooth muscle cells in response to IFN-gamma and TNF-alpha and is modulated by metalloproteinase activityJ Immunol1686041211777952
   PubMed Web of Science ®Google Scholar
• MatsunawaMIsozakiTOdaiT2006Increased serum levels of soluble fractalkine (CX3CL1) correlate with disease activity in rheumatoid vasculitisArthritis Rheum5434081617075825
   PubMed Web of Science ®Google Scholar
• NankiTImaiTNagasakaK2002Migration of CX3CR1-positive T cells producing type 1 cytokines and cytotoxic molecules into the synovium of patients with rheumatoid arthritisArthritis Rheum4628788312428227
   PubMed Web of Science ®Google Scholar
• PaludanSR2000Synergistic action of pro-inflammatory agents: cellular and molecular aspectsJ Leukoc Biol67182510647993
   PubMed Web of Science ®Google Scholar
• RuthJHVolinMVHainesGK3rd2001Fractalkine, a novel chemokine in rheumatoid arthritis and in rat adjuvant-induced arthritisArthritis Rheum4415688111465708
   PubMed Web of Science ®Google Scholar
• ShinodaKSugiyamaETakiH2003Resting T cells negatively regulate osteoclast generation from peripheral blood monocytesBone337112014555277
   PubMed Web of Science ®Google Scholar
• ShulbySADolloffNGStearnsME2004CX3CR1-fractalkine expression regulates cellular mechanisms involved in adhesion, migration, and survival of human prostate cancer cellsCancer Res644693815256432
   PubMed Web of Science ®Google Scholar
• TakPPBresnihanB2000The pathogenesis and prevention of joint damage in rheumatoid arthritis: Advances from synovial biopsy and tissue analysisArthritis Rheum4326193311145019
   PubMed Web of Science ®Google Scholar
• TakayanagiHSatoKTakaokaA2005Interplay between interferon and other cytokine systems in bone metabolismImmunol Rev2081819316313349
   PubMed Web of Science ®Google Scholar
• TakeshitaAChenYWatanabeA1995TGF-beta induces expression of monocyte chemoattractant JE/monocyte chemoattractant protein 1 via transcriptional factor AP-1 induced by protein kinase in osteoblastic cellsJ Immunol155419267602115
   PubMed Web of Science ®Google Scholar
• UdagawaNKotakeSKamataniN2002The molecular mechanism of osteoclastogenesis in rheumatoid arthritisArthritis Res4281912223101
   PubMedGoogle Scholar
• UmeharaHBloomEOkazakiT2001Fractalkine and vascular injuryTrends Immunol22602711698220
   PubMed Web of Science ®Google Scholar
• van RoonJAvan RoyJLDuitsA1995Proinflammatory cytokine production and cartilage damage due to rheumatoid synovial T helper-1 activation is inhibited by interleukin-4Ann Rheum Dis54836407492224
   PubMed Web of Science ®Google Scholar
• VolinMVWoodsJMAminMA2001Fractalkine: a novel angiogenic chemokine in rheumatoid arthritisAm J Pathol15915213011583978
   PubMed Web of Science ®Google Scholar
• WangFSenguptaTKZhongZ1995Regulation of the balance of cytokine production and the signal transducer and activator of transcription (STAT) transcription factor activity by cytokines and inflammatory synovial fluidsJ Exp Med1821825317500028
   PubMed Web of Science ®Google Scholar
• YajimaNKasamaTIsozakiT2005Elevated levels of soluble fractalkine in active systemic lupus erythematosus: Potential involvement in neuropsychiatric manifestationsArthritis Rheum521670515934075
   PubMed Web of Science ®Google Scholar
• YoshidaHImaizumiTFujimotoK2001Synergistic stimulation, by tumor necrosis factor-alpha and interferon-gamma, of fractalkine expression in human astrocytesNeurosci Lett303132611311510
   PubMed Web of Science ®Google Scholar
• ZhuJFValenteAJLorenzoJA1994Expression of monocyte chemoattractant protein 1 in human osteoblastic cells stimulated by proinflammatory mediatorsJ Bone Miner Res91123307942160
   PubMed Web of Science ®Google Scholar